ArticleHealth science reports2026
Resurgence of Ebola in the Democratic Republic of Congo: Lessons Learned and Future Directions.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The Democratic Republic of the Congo (DRC) remains the global epicenter of Ebola virus disease (EVD), having experienced more than 15 outbreaks since the disease was first identified in 1976. The 2025 resurgence in Kasai Province, caused by Methods: This perspective synthesizes evidence from publicly available reports, epidemiological updates, genomic surveillance findings, and guidance from national and international public health agencies to examine the epidemiological characteristics, health system challenges, response interventions, and lessons learned from the 2025 Ebola outbreak in the DRC. Results: Genomic evidence suggested viral persistence in human reservoirs as a likely source of the outbreak. Delayed diagnosis due to limited laboratory capacity, reagent shortages, and slow sample transportation impeded timely case confirmation. Sociocultural factors, including unsafe burial practices, vaccine hesitancy, and community mistrust, further complicated containment efforts. The outbreak overwhelmed fragile health systems, with inadequate isolation facilities and personal protective equipment contributing to healthcare worker infections, which accounted for 10% of reported cases. Coordinated national and international interventions, including emergency response activation, ring vaccination with the rVSVΔG-ZEBOV-GP (Ervebo) vaccine, enhanced surveillance, contact tracing, infection prevention and control measures, and technical support from global partners, were instrumental in interrupting transmission. Conclusion: The 2025 Ebola outbreak demonstrates the continued threat of recurrent EVD in the DRC and underscores the need for resilient surveillance systems, decentralized laboratory capacity, sustained infection prevention and control measures, healthcare worker protection, meaningful community engagement, and strengthened regional collaboration. Integrating genomic surveillance and advancing vaccine research will be critical for improving epidemic preparedness and strengthening health security across Central Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.